Flexibility of Oral Cholera Vaccine Dosing—A Randomized Controlled Trial Measuring Immune Responses Following Alternative Vaccination Schedules in a Cholera Hyper-Endemic Zone

BACKGROUND: A bivalent killed whole cell oral cholera vaccine has been found to be safe and efficacious for five years in the cholera endemic setting of Kolkata, India, when given in a two dose schedule, two weeks apart. A randomized controlled trial revealed that the immune response was not signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanungo, Suman, Desai, Sachin N., Nandy, Ranjan Kumar, Bhattacharya, Mihir Kumar, Kim, Deok Ryun, Sinha, Anuradha, Mahapatra, Tanmay, Yang, Jae Seung, Lopez, Anna Lena, Manna, Byomkesh, Bannerjee, Barnali, Ali, Mohammad, Dhingra, Mandeep Singh, Chandra, Ananga Mohan, Clemens, John D., Sur, Dipika, Wierzba, Thomas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357440/
https://www.ncbi.nlm.nih.gov/pubmed/25764513
http://dx.doi.org/10.1371/journal.pntd.0003574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357440/
https://www.ncbi.nlm.nih.gov/pubmed/25764513
http://dx.doi.org/10.1371/journal.pntd.0003574

Ejemplares similares